Clinical Trial: Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751081) titled 'Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders' on July 29.

Brief Summary: The study is a double-blind, placebo-controlled, crossover, randomised trial, in which enrolled subjects will be included for 18 months. This study aims to evaluate the effect of the Colipral as a Food Supplement prescribed according to the standard of care of patients suffering UC during remission phase and DGBI.

The primary objective of the study is to evaluate the variation in gut microbiota, specifically focusing on bacterial diversity and a...